These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34183384)

  • 1. Genetic Analysis in Anal and Cervical Cancer: Exploratory Findings About Radioresistance in the ProfiLER Database.
    Rowinski E; Magne N; Bouleftour W; Moreno-Acosta P; DE LA Fourchadiere C; Ray-Coquard I; Wang Q; Blay JY; Tredan O
    Cancer Genomics Proteomics; 2021; 18(4):515-520. PubMed ID: 34183384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
    Mouw KW; Cleary JM; Reardon B; Pike J; Braunstein LZ; Kim J; Amin-Mansour A; Miao D; Damish A; Chin J; Ott PA; Fuchs CS; Martin NE; Getz G; Carter S; Mamon HJ; Hornick JL; Van Allen EM; D'Andrea AD
    Clin Cancer Res; 2017 Jun; 23(12):3214-3222. PubMed ID: 27852700
    [No Abstract]   [Full Text] [Related]  

  • 3. Genome-wide host methylation profiling of anal and cervical carcinoma.
    Siegel EM; Ajidahun A; Berglund A; Guerrero W; Eschrich S; Putney RM; Magliocco A; Riggs B; Winter K; Simko JP; Ajani JA; Guha C; Okawara GS; Abdalla I; Becker MJ; Pizzolato JF; Crane CH; Brown KD; Shibata D
    PLoS One; 2021; 16(12):e0260857. PubMed ID: 34882728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
    Lee SY; Chae DK; Lee SH; Lim Y; An J; Chae CH; Kim BC; Bhak J; Bolser D; Cho DH
    BMC Cancer; 2020 Jul; 20(1):694. PubMed ID: 32718341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub-analysis of the ProfiLER protocol.
    Rowinski E; Magné N; Fayette J; Daguenet E; Racadot S; Pommier P; Méry B; Vallard A; Tinquaut F; Neidhardt-Berard EM; Cassier P; Attignon V; Pissaloux D; Wang Q; Sohier E; Pérol D; Blay JY; Trédan O
    Head Neck; 2021 Dec; 43(12):3899-3910. PubMed ID: 34643313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of PIK3CA and MDM2 SNP309 with Cervical Squamous Cell Carcinoma in a Philippine Population.
    Tantengco OAG; Nakura Y; Yoshimura M; Llamas-Clark EF; Yanagihara I
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2103-2107. PubMed ID: 31350972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer.
    Mondaca S; Chatila WK; Bates D; Hechtman JF; Cercek A; Segal NH; Stadler ZK; Varghese AM; Kundra R; Capanu M; Shia J; Schultz N; Saltz L; Yaeger R
    Clin Colorectal Cancer; 2019 Mar; 18(1):e39-e52. PubMed ID: 30316684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.
    Van Damme N; Deron P; Van Roy N; Demetter P; Bols A; Van Dorpe J; Baert F; Van Laethem JL; Speleman F; Pauwels P; Peeters M
    BMC Cancer; 2010 May; 10():189. PubMed ID: 20459770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.
    Hamza A; Masliah-Planchon J; Neuzillet C; Lefèvre JH; Svrcek M; Vacher S; Bourneix C; Delaye M; Goéré D; Dartigues P; Samalin E; Hilmi M; Lazartigues J; Girard E; Emile JF; Rigault E; Dangles-Marie V; Rioux-Leclercq N; de la Fouchardière C; Tougeron D; Casadei-Gardini A; Mariani P; Peschaud F; Cacheux W; Lièvre A; Bièche I
    Int J Cancer; 2024 Feb; 154(3):504-515. PubMed ID: 37908048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
    Wright AA; Howitt BE; Myers AP; Dahlberg SE; Palescandolo E; Van Hummelen P; MacConaill LE; Shoni M; Wagle N; Jones RT; Quick CM; Laury A; Katz IT; Hahn WC; Matulonis UA; Hirsch MS
    Cancer; 2013 Nov; 119(21):3776-83. PubMed ID: 24037752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing of cervical high grade dysplasia and invasive squamous cell carcinoma: A case study.
    Vormittag-Nocito E; Groth JV; Mohapatra G
    Pathol Res Pract; 2020 Apr; 216(4):152863. PubMed ID: 32098697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).
    Casadei Gardini A; Capelli L; Ulivi P; Giannini M; Freier E; Tamberi S; Scarpi E; Passardi A; Zoli W; Ragazzini A; Amadori D; Frassineti GL
    PLoS One; 2014; 9(3):e92071. PubMed ID: 24642661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational profiles of marker genes of cervical carcinoma in Bangladeshi patients.
    Sharmin S; Zohura FT; Islam MS; Shimonty A; Khan MA; Parveen R; Sharmin F; Ahsan CR; Islam ABMMK; Yasmin M
    BMC Cancer; 2021 Mar; 21(1):289. PubMed ID: 33736612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes with anti-EGFR monoclonal antibodies in metastatic and recurrent anal squamous cell carcinoma.
    Rogers JE; Jácome AAA; Ohinata A; Wolff R; Morris VK; Johnson B; Mehdizadeh A; Rothschild ND; Ahmed SU; Guerra JL; Eng C
    Expert Rev Anticancer Ther; 2020 Oct; 20(10):901-908. PubMed ID: 32799569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of Kruppel-like factor 4 as a predictor of poor prognosis for cervical cancer patient response to radiotherapy.
    Liu HX; Li N; Wei L; Zhou FX; Ma R; Xiao F; Zhang W; Zhang Y; Hui YP; Song H; Chen BL
    Tumour Biol; 2017 Jun; 39(6):1010428317710225. PubMed ID: 28639905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression changes in residual advanced cervical cancer after radiotherapy: indicators of poor prognosis and radioresistance?
    Fu ZC; Wang FM; Cai JM
    Med Sci Monit; 2015 May; 21():1276-87. PubMed ID: 25940978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study.
    Siegel EM; Eschrich S; Winter K; Riggs B; Berglund A; Ajidahun A; Simko J; Moughan J; Ajani J; Magliocco A; Elahi A; Hoffe S; Shibata D
    Dis Colon Rectum; 2014 Aug; 57(8):941-57. PubMed ID: 25003289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.
    Chung JH; Sanford E; Johnson A; Klempner SJ; Schrock AB; Palma NA; Erlich RL; Frampton GM; Chalmers ZR; Vergilio J; Rubinson DA; Sun JX; Chmielecki J; Yelensky R; Suh JH; Lipson D; George TJ; Elvin JA; Stephens PJ; Miller VA; Ross JS; Ali SM
    Ann Oncol; 2016 Jul; 27(7):1336-41. PubMed ID: 27052656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
    Chau NG; Li YY; Jo VY; Rabinowits G; Lorch JH; Tishler RB; Margalit DN; Schoenfeld JD; Annino DJ; Goguen LA; Thomas T; Becker H; Haddad T; Krane JF; Lindeman NI; Shapiro GI; Haddad RI; Hammerman PS
    Clin Cancer Res; 2016 Jun; 22(12):2939-49. PubMed ID: 26763254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the Genomic Landscape in Cervical Cancer by Next Generation Sequencing.
    Qiu L; Feng H; Yu H; Li M; You Y; Zhu S; Yang W; Jiang H; Wu X
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.